findmyKOL

Halis Sonmez, MD

Basic profile

Northwell Health

ORCIDNPI
RegionRego Park, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Halis Sonmez is an Endocrinology/Metabolic physician affiliated with Northwell Health. OpenAlex indexes 10 publications with 487 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex, matched via ORCID.

487citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

9785 Queens Blvd
Rego Park, NY 113743319

Telephone

718-261-9100

Provider last certified this registry record 2 Apr 2021.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    63.1%
    GLP-1 receptor agonist18.4%
    Mounjaro43%Ozempic32%Rybelsus14%Trulicity10%
    Part D102 patients
    Insulin Analog10.5%
    Novolog Flexpen26%Lantus Solostar18%Tresiba Flextouch U-10012%Basaglar Kwikpen U-10012%Tresiba Flextouch U-20011%Humalog Kwikpen U-1008%Insulin Aspart Flexpen5%Fiasp Flextouch4%Insulin Lispro Kwikpen U-1002%Admelog Solostar2%
    Part D<11 patients

    + 7 more classes in this area

  • Cardiovascular

    17.6%
    Statin7.3%
    Atorvastatin Calcium47%Rosuvastatin Calcium47%Simvastatin7%
    Part D<11 patients
    Other lipid modifying agents4.2%
    Vascepa81%Icosapent Ethyl19%
    Part D44 patients

    + 6 more classes in this area

  • Hormonal (systemic)

    17%
    l-Thyroxine13.8%
    Synthroid55%Levothyroxine Sodium44%Unithroid1%
    Part D<11 patients
    l-Triiodothyronine0.9%
    Liothyronine Sodium100%
    Part D13 patients

    + 5 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”